A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes

Clinical trial NCT00838916 · COMPLETED

Trial details

NCT number: NCT00838916
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2009-02-01
Primary completion: 2012-01-01
Enrollment: 779

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.